Severe Hemophilia A Completed Phase 3 Trials for Antihemophilic factor human (DB13192)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02954575Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia ATreatment
NCT03376516Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia ATreatment
NCT02502149Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) ScaleOther